Wellington Management Group
RVMD icon

Wellington Management Group’s Revolution Medicines RVMD Stock Holding History

Wellington Management Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$586M Sell
6,027,819
-959,820
-14% -$96.9M 0.11% 189
2025
Q4 		$557M Sell
6,987,639
-2,825,797
-29% -$185M 0.1% 193
2025
Q3 		$458M Sell
9,813,436
-446,302
-4% -$17.5M 0.08% 217
2025
Q2 		$377M Sell
10,259,738
-1,528,183
-13% -$58.7M 0.07% 234
2025
Q1 		$417M Buy
11,787,921
+966,230
+9% +$39.2M 0.08% 210
2024
Q4 		$473M Sell
10,821,691
-579,703
-5% -$29.3M 0.09% 196
2024
Q3 		$517M Sell
11,401,394
-2,258,802
-17% -$98.4M 0.09% 197
2024
Q2 		$530M Sell
13,660,196
-1,054,530
-7% -$39.4M 0.09% 200
2024
Q1 		$474M Sell
14,714,726
-167,360
-1% -$4.96M 0.08% 230
2023
Q4 		$427M Buy
14,882,086
+4,309,611
+41% +$104M 0.08% 237
2023
Q3 		$293M Buy
10,572,475
+282,786
+3% +$8.39M 0.06% 291
2023
Q2 		$275M Sell
10,289,689
-135,679
-1% -$3.33M 0.05% 326
2023
Q1 		$226M Buy
10,425,368
+1,551,394
+17% +$38.2M 0.04% 367
2022
Q4 		$211M Buy
8,873,974
+1,492,795
+20% +$31.7M 0.04% 372
2022
Q3 		$146M Buy
7,381,179
+1,212,177
+20% +$26.6M 0.03% 434
2022
Q2 		$120M Buy
6,169,002
+2,085,013
+51% +$40.6M 0.02% 492
2022
Q1 		$104M Sell
4,083,989
-426,906
-9% -$9.29M 0.02% 574
2021
Q4 		$114M Sell
4,510,895
-26,207
-0.6% -$739K 0.02% 598
2021
Q3 		$125M Sell
4,537,102
-1,041,946
-19% -$30.3M 0.02% 560
2021
Q2 		$177M Buy
5,579,048
+1,658,400
+42% +$57.9M 0.03% 469
2021
Q1 		$180M Buy
3,920,648
+3,688,457
+1,589% +$165M 0.03% 444
2020
Q4 		$9.19M Buy
232,191
+28,352
+14% +$1.12M ﹤0.01% 1206
2020
Q3 		$7.09M Sell
203,839
-78,902
-28% -$2.19M ﹤0.01% 1185
2020
Q2 		$8.93M Sell
282,741
-53,924
-16% -$1.7M ﹤0.01% 1094
2020
Q1 		$7.38M Buy
+336,665
New +$9.32M ﹤0.01% 1113

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Wellington Management Group's RVMD Position: Q1 2026 in Review

Wellington Management Group reduced its Revolution Medicines (RVMD) stake by 14% in Q1 2026, selling an estimated $96.9M and leaving 6,027,819 shares worth $586M. The position accounts for 0.11% of the portfolio, ranked #189.

Wellington Management Group first reported a position in RVMD in Q1 2020 and has held it in 25 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Wellington Management Group held 6,027,819 shares of Revolution Medicines worth $586M as of Q1 2026.
  • Wellington Management Group sold 959,820 Revolution Medicines shares in Q1 2026, an estimated $96.9M.
  • Revolution Medicines made up 0.11% of Wellington Management Group's portfolio in Q1 2026, its #189 holding.
  • Wellington Management Group first reported a position in Revolution Medicines in Q1 2020 and has held it in 25 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.